Development and validation of a simple sensitive enzyme immunoassay (EIA) for GH determination in buffalo plasma

A simple and highly sensitive enzymeimmunoassay (EIA) for GH determination in buffalo plasma on microtitreplates using biotin-streptavidin amplification system and the second antibody coating was developed. Biotin was coupled to GH and used to bridge between streptavidin-peroxidase and immobilized antiserum in competitive assay. The EIA was carried out directly in 100 muL buffalo plasma. The GH standards ranging from 0.05ng/well/100muL to 12.8 ng/well/100 muL were prepared in hormone free plasma collected from an aged (>15 years) senile buffalo. The sensitivity of the EIA procedure was 50pg/well GH, which corresponded to 0.50ng/mL plasma; the 50% relative binding sensitivity was seen at 800 pg/well/100muL. Plasma volumes for the EIA, viz., 25, 50, and 100muL did not influence the shape of standard curve, even though a slight drop in the OD450 was seen with higher plasma volumes. For the biological validation of the assay, 12 Murrah buffalo calves were used. Six of these were administered synthetic bovine growth hormone-releasing factor (10mug/100 kg body weight, i.v., and the remaining six animals were administered sterile normal saline and kept as controls. Jugular blood samples were collected at -60, -45, -30, -15, -10, -5, 5, 10, 15, and 30 min and, thereafter, Lit an interval of 15 min using an indwelling jugular catheter, beginning 1 h prior to GRF injection up to 8 h post treatment. In all animals, a peak of GH was recorded within 5 to 20 min of GRF administration, which confirms the biological validation of the EIA. To confirm homogeneity of buffalo GH with bovine GH, a parallelism test was conducted between the buffer standard curve of bovine GH and GH measured from serial dilution of buffalo plasma containing a high level of endogenous growth hormone.